PIGNANI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 444
AS - Asia 181
EU - Europa 158
SA - Sud America 7
AF - Africa 1
OC - Oceania 1
Totale 792
Nazione #
US - Stati Uniti d'America 441
CN - Cina 80
IT - Italia 75
SG - Singapore 31
TR - Turchia 29
DE - Germania 24
PL - Polonia 20
UA - Ucraina 16
ID - Indonesia 15
SE - Svezia 8
GB - Regno Unito 7
CO - Colombia 6
HK - Hong Kong 6
JP - Giappone 5
KR - Corea 5
IR - Iran 4
CA - Canada 3
VN - Vietnam 3
FI - Finlandia 2
NO - Norvegia 2
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
FR - Francia 1
GE - Georgia 1
MY - Malesia 1
NL - Olanda 1
RU - Federazione Russa 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 792
Città #
Chandler 67
Fairfield 46
Ferrara 33
Izmir 29
Woodbridge 29
Houston 23
Singapore 22
Nanjing 20
Warsaw 20
Ann Arbor 19
Wilmington 19
Seattle 17
Ashburn 16
Jacksonville 15
Jakarta 14
Princeton 14
Cambridge 13
Shanghai 13
New York 11
Milan 10
Dearborn 8
Beijing 7
Los Angeles 7
Piemonte 7
Santa Clara 7
Bremen 6
Medellín 6
Bologna 5
Changsha 5
Hebei 5
Cagliari 4
San Diego 4
Chicago 3
Dong Ket 3
Falls Church 3
Ferrara di Monte Baldo 3
Guangzhou 3
Jinan 3
Ningbo 3
Redwood City 3
Toronto 3
Alexandria 2
Andover 2
Belvedere Spinello 2
Hangzhou 2
Hong Kong 2
Leawood 2
London 2
Nanchang 2
Oslo 2
Seocho-gu 2
Seongbuk-gu 2
Tabriz 2
Zhengzhou 2
Augusta 1
Balk 1
Bloemfontein 1
Boardman 1
Brno 1
Chongqing 1
Dundee 1
Fars 1
Glenside 1
Haikou 1
Helsinki 1
Henderson 1
Hounslow 1
Jiaxing 1
Kunming 1
Moscow 1
Munich 1
Nandlstadt 1
Newcastle 1
Paris 1
Persiceto 1
Porto Garibaldi 1
Prescot 1
Qingdao 1
Redmond 1
Rio De Janeiro 1
Sabz 1
San Mateo 1
Seocho 1
Shaoxing 1
Shenyang 1
St Louis 1
Taipei 1
Tianjin 1
Triggiano 1
Varese 1
Totale 610
Nome #
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 149
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 110
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 104
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 74
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 67
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 65
CRISPR activation on coagulation F7 or F8 promoters potentiate trascriptional activity in the normal and mutated gene context 57
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 54
Engineered transcription factors (TALE-TF) as potential therapeutic strategy for coagulation factor deficiencies caused by promoter mutations 46
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 44
Modulation at transcriptional and post-translational level to develop therapeutic approaches for coagulation factor deficiencies 34
Base and Prime editing of DNA as a new therapeutic option for Hemophilia A 18
New Genome Editing Approaches: Base And Prime Editing To Revert Hemophilia A-Causing Point Mutations 8
Totale 830
Categoria #
all - tutte 4.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202096 0 0 5 18 13 18 13 7 10 5 3 4
2020/2021104 1 4 2 9 4 2 20 17 16 12 11 6
2021/2022106 7 14 1 3 6 5 1 1 5 7 5 51
2022/2023137 13 21 1 20 21 16 11 7 17 1 5 4
2023/202492 7 9 10 2 7 12 5 6 1 6 5 22
2024/202556 9 20 27 0 0 0 0 0 0 0 0 0
Totale 830